Key points are not available for this paper at this time.
Objectives Between 2016-19, the proportion of Escherichia coli bloodstream infection (BSI) with resistance to at least one antibiotic increased nationally. Public health interventions implemented in response to the coronavirus disease 2019 (COVID-19) pandemic changed population contact patterns and healthcare systems, with consequent effects on epidemiological trends of numerous pathogens. We investigated the impact of COVID-19 restrictions on epidemiological trends of E. coli BSI antimicrobial resistance (AMR) across South West England. Methods We undertook a retrospective ecological analysis utilising routine surveillance data of E. coli BSI cases reported to the UK Health Security Agency between 2016-2021. We analysed AMR trends for antimicrobial agents including amoxicillin-clavulanate, ciprofloxacin, piperacillin-tazobactam, gentamicin, third-generation cephalosporins and carbapenems before and after implementation of COVID-19 restrictions (23/03/2020) using Bayesian segmented regression. Results We identified 19,055 cases. 50.2% were male. Median age was 76 (interquartile range 65-85). Piperacillin-tazobactam (-2.90% 95% Highest Density Interval (HDI) -4.51%, -0.48%) and ciprofloxacin (-2.40% 95% HDI -4.35%, 0.48%) resistance demonstrated immediate step changes at implementation of COVID-19 restrictions. Gentamicin (Odds Ratio (OR) 0.92 95% HDI 0.76, 1.12) and third-generation cephalosporins (OR 0.95 95% HDI 0.80, 1.14) exhibited decreasing annual resistance trends following implementation of COVID-19 restrictions, with moderate evidence for a lower OR after restrictions as compared to the period before (gentamicin Bayes Factor (BF)=5.10, third-generation cephalosporins BF=6.67). Conclusions COVID-19 restrictions led to abrupt and longer-term changes to E.coli BSI AMR. The immediate effects suggest altered transmission, while changes to resistant E. coli reservoirs may explain trend effects.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jack Stanley
University of Leeds
Brian Sullivan
IDEXX Laboratories (France)
Andrew W. Dowsey
At Bristol
Clinical Microbiology and Infection
University of Bristol
National Institute for Health Research
UK Health Security Agency
Building similarity graph...
Analyzing shared references across papers
Loading...
Stanley et al. (Sat,) studied this question.
synapsesocial.com/papers/68e72a7db6db6435876a46ca — DOI: https://doi.org/10.1016/j.cmi.2024.03.018
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: